Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 125 of 249 entries
View as:

Efficacy and Safety of Paclitaxel (Albumin-bound) Combination With Carboplatin in Ovarian Cancer.

Phase: N/A Priority: Normal
NCT ID: NCT04661696 Org: User:
Start: 12/09/20 End: 02/23/24 Due: 02/23/25

SOX as Adjuvant Chemotherapy for Resectable Gastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01542294 Org: User:
Start: 06/30/11 End: 04/30/17 Due: 04/30/18

The Phase IVa of Inactivated Enterovirus 71 Vaccine (Human Diploid Cell, KMB-17)

Phase: N/A Priority: Normal
NCT ID: NCT02999828 Org: User:
Start: 09/30/16 End: 02/28/19 Due: 02/28/20

Study of IMRT Radiotherapy Concurrent Chemothrerapy for Anal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03381352 Org: User:
Start: 12/02/15 End: 12/31/20 Due: 12/31/21

Comparison Study of Neoadjuvant Paclitaxel Plus Carboplatin/Epirubicin Treatment in Triple-negative Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01276769 Org: User:
Start: 01/31/08 End: 07/31/12 Due: 07/31/13

Online Noninvasive Assessment of Human Brain Death and Deep Coma by Near-infrared Spectroscopy

Phase: N/A Priority: Normal
NCT ID: NCT04623294 Org: User:
Start: 11/10/20 End: 12/31/22 Due: 12/31/23

Study of Apatinib Combined With Oral Vinorelbine in Metastatic HER2 Negative Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02768415 Org: User:
Start: 06/30/16 End: - Due: -

Adjuvant Radiotherapy for pT1b Esophageal Cancer After Submucosal Endoscopic Resection

Phase: N/A Priority: Normal
NCT ID: NCT05499195 Org: User:
Start: 03/01/21 End: 06/30/22 Due: 06/30/23

Phase I Study of Novel Estrogen Receptor(ER) a36 Modifier Icaritin in Advanced Breast Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT01278810 Org: User:
Start: 11/30/10 End: 12/31/11 Due: 12/31/12

Nimotuzumab Combined With Radiotherapy for Older Patients With Esophageal Cancer: a Single, Non-control Clinical Trial

Phase: N/A Priority: Normal
NCT ID: NCT01463605 Org: User:
Start: 06/30/11 End: 02/29/20 Due: 02/28/21

Ibrutinib Combined With Rituximab for Treatment of Relapsed Refractory MYD88 and CD79A/B (or CD79B Alone) DLBCL Who Have Received at Least Two Prior Therapies

Phase: N/A Priority: Normal
NCT ID: NCT04994626 Org: User:
Start: 10/01/21 End: 07/01/25 Due: 07/01/26

Capecitabine (NX) Versus Docetaxel Plus Capecitabine (TX) as 1-line Chemotherapy on Metastatic Breast Cancer (MBC)

Phase: N/A Priority: Normal
NCT ID: NCT01126138 Org: User:
Start: 07/31/10 End: 08/31/15 Due: 08/31/16

Adjuvant Chemotherapy With Paclitaxel and Cisplatin in Lymph Node-Positive Thoracic Esophageal Squamous Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT02133612 Org: User:
Start: 12/31/07 End: 05/31/14 Due: 05/31/15

Raltitrexed and Paclitaxel for Gastric or Gastroesophageal Junction Adenocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT03083613 Org: User:
Start: 05/31/15 End: 12/01/18 Due: 12/01/19

The Study of Exosome EML4-ALK Fusion in NSCLC Clinical Diagnosis and Dynamic Monitoring

Phase: N/A Priority: Normal
NCT ID: NCT04499794 Org: User:
Start: 08/01/20 End: 03/31/25 Due: 03/31/26

Temozolomide for Injection Combined With Epirubicin in First-line Treatment of Leiomyosarcoma

Phase: N/A Priority: Normal
NCT ID: NCT05204524 Org: User:
Start: 08/27/21 End: 08/27/23 Due: 08/27/24

The Clinical Effect of Adaptive Posture-balance Cardiac Rehabilitation Exercise on Cardiovascular Diseases

Phase: N/A Priority: Normal
NCT ID: NCT05496153 Org: User:
Start: 12/01/20 End: 10/31/21 Due: 10/31/22

Pyrotinib Plus Fulvestrant in Patients With HR+/HER2+ Metastatic Breast Cancer (Pyrotinib+Fulvestrant )

Phase: N/A Priority: Normal
NCT ID: NCT04033172 Org: User:
Start: 11/01/18 End: 09/01/21 Due: 09/01/22

Endoscopic Screening on Esophageal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02094105 Org: User:
Start: 11/30/99 End: 12/31/13 Due: 12/31/14

Tomotherapy as Primary Radiotherapy for Multipule Brain Metastases

Phase: N/A Priority: Normal
NCT ID: NCT04178330 Org: User:
Start: 09/01/14 End: 06/13/17 Due: 06/13/18

Phase II Study of Capecitabine and Cisplatin to Treat Metastatic Triple Negative Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01928680 Org: User:
Start: 11/30/12 End: 03/31/16 Due: 03/31/17

Clinical Study of the Third Dose Immunization Schedule of COVID-19 Inactivated Vaccine, (Vero Cells) in Adults Aged 18 Years and Above

Phase: N/A Priority: Normal
NCT ID: NCT05164731 Org: User:
Start: 12/16/21 End: 10/30/22 Due: 10/30/23

Real-world Treatment Patterns and Clinical Outcomes in EGFR-mutant Unresectable Locally Advanced NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT04304638 Org: User:
Start: 03/31/20 End: 06/30/20 Due: 06/30/21

Clinical Study of Albumin-bound Paclitaxel Plus Nedaplatin in Cervical Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01667211 Org: User:
Start: 11/30/11 End: 12/31/16 Due: 12/31/17

GR1405 Injection in Patients With Advanced Solid Tumor or Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT03731390 Org: User:
Start: 11/30/18 End: 10/31/21 Due: 10/31/22